drugset / Trial / NCT02709564
Sublingual Misoprostol in Decreasing Blood Loss Prior to Myomectomy
RandomizedParallel-groupTriple-blindPrevention
Summary
The aim of the study is to compare the effectiveness of sublingual administered prostaglandin E1 synthetic analogue (misoprostol) 400 microgram versus placebo before myomectomy to decrease blood loss during and after the operation.
Timeline
- Start
- 2016-12
- Primary completion
- 2019-12
- Completion
- 2020-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Misoprostol | Other / unclassified | 400 ug | Other |
Indications
No indication recorded.